Association of Hippocampal Subfield Volumes with Amyloid-Beta Deposition in Alzheimer's Disease.
Min Seok BaekNarae LeeJin Woo KimJin Yong HongPublished in: Journal of clinical medicine (2022)
We investigated the relationship between hippocampal subfield volumes and cortical amyloid-beta (Aβ) deposition in Alzheimer's disease (AD). Fifty participants (11 cognitively unimpaired [CU], 10 with mild cognitive impairment [MCI], and 29 with AD) who underwent 18 F-florbetaben positron emission tomography, magnetic resonance imaging, and neuropsychological tests were enrolled. The hippocampal subfield volumes were obtained using an automated brain volumetry system with the Winterburn atlas and were compared among the diagnostic groups, and the correlations with the Aβ deposition and AD risk factors were determined. Patients with MCI and AD showed decreased volume in the stratum radiatum/lacunosum/moleculare (SRLM) of the cornu ammonis (CA)1 and CA4-dentate gyrus (DG) compared with the CU. Decreased SRLM and CA4-DG volumes were associated with an increased Aβ deposition in the global cortex (R = -0.459, p = 0.001; R = -0.393, p = 0.005, respectively). The SRLM and CA4-DG volumes aided in the distinction of AD from CU (areas under the receiver operating characteristic [AUROC] curve = 0.994 and 0.981, respectively, p < 0.001), and Aβ+ from Aβ- individuals (AUROC curve = 0.949 and 0.958, respectively, p < 0.001). Hippocampal subfield volumes demonstrated potential as imaging biomarkers in the diagnosis and detection of AD and Aβ deposition, respectively.
Keyphrases
- mild cognitive impairment
- cognitive decline
- positron emission tomography
- magnetic resonance imaging
- computed tomography
- risk factors
- cerebral ischemia
- high resolution
- protein kinase
- temporal lobe epilepsy
- pet ct
- brain injury
- functional connectivity
- white matter
- aqueous solution
- blood brain barrier
- risk assessment
- multiple sclerosis
- atomic force microscopy
- photodynamic therapy
- contrast enhanced